CN Patent

CN104107178B — 一种用于治疗鼻炎的药物组合物

Assigned to Individual · Expires 2016-06-22 · 10y expired

What this patent protects

本发明公开了一种用于治疗鼻炎的药物组合物，其特征在于含有氮卓斯汀以及柠檬醛为有效成分。所述氮卓斯汀的含量为0.001％～0.5％；所述柠檬醛的含量为0.01％～5％。还可以根据需要加入药学上许可量的载体和/或增溶剂、赋形剂。

USPTO Abstract

本发明公开了一种用于治疗鼻炎的药物组合物，其特征在于含有氮卓斯汀以及柠檬醛为有效成分。所述氮卓斯汀的含量为0.001％～0.5％；所述柠檬醛的含量为0.01％～5％。还可以根据需要加入药学上许可量的载体和/或增溶剂、赋形剂。

Drugs covered by this patent

azelastine-hydrochloride (AZELASTINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN104107178B
Jurisdiction: CN
Classification: —
Expires: 2016-06-22
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.